Tuberculosis
📧 Sign up to get email alerts when something new happens for Tuberculosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2020-12-21Clinical Trial Update: Safety, Tolerance and Pharmacokinetics of Raltegravir-Containing Antiretroviral Therapy in Infants, Children Infected With HIV and TB [Phase 1, Phase 2]
Phase 1/2 trial assessing safety, tolerance, and pharmacokinetics of raltegravir-containing ART in infants and children with HIV and tubercu…
-
CLINICAL_TRIALS trial_result · 2020-11-12Clinical Trial Update: Pharmacokinetic Interaction Study in Indonesian Tuberculosis Patients Indonesia [Phase 2]
Phase 2 pharmacokinetic interaction study in Indonesian tuberculosis patients has completed.
-
CLINICAL_TRIALS trial_result · 2020-10-12Clinical Trial Update: Immunogenicity and Safety of a Candidate Tuberculosis (TB) Vaccine Given to Healthy Adults in a TB-endemic Region [Phase 2]
Phase 2 trial assessing immunogenicity and safety of a TB vaccine candidate in healthy adults in a TB-endemic region; study completed.
-
CLINICAL_TRIALS trial_result · 2020-10-01Clinical Trial Update: Clinical Study of Recombinant Mycobacterium Tuberculosis Allergen ESAT6-CFP10 on Healthy People Aged 18-65(III-healthy) [Phase 3]
Phase 3 trial of recombinant ESAT6-CFP10 allergen for tuberculosis in healthy adults completed.
-
CLINICAL_TRIALS trial_result · 2020-08-31Clinical Trial Update: MVA85A Aerosol vs Intramuscular Vaccination in Adults With Latent Mycobacterium Tuberculosis (M. tb) Infection [Phase 1]
Phase 1 trial update comparing MVA85A aerosol vs intramuscular vaccination in adults with latent TB infection; study terminated with results…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2020-08-18Clinical Trial Update: Effects of a Protein Calorie Supplement in HIV-infected Women With Tuberculosis [NA]
A completed clinical trial evaluating the effects of a protein-calorie supplement in HIV-infected women with tuberculosis; results posted in…
-
CLINICAL_TRIALS trial_result · 2020-08-14Clinical Trial Update: Efficacy of 400 mg Efavirenz Versus Standard 600 mg Dose in HIV/TB Co-infected Patients [Phase 3]
Phase 3 trial comparing efficacy of 400 mg efavirenz versus standard 600 mg dose in HIV/TB co-infected patients; current status unknown.
-
CLINICAL_TRIALS trial_result · 2020-08-05Clinical Trial Update: A 14 Day Early Bactericidal Activity Study of Nitazoxanide for the Treatment of Tuberculosis [Phase 2]
Phase 2 clinical trial update evaluating 14-day early bactericidal activity of nitazoxanide for tuberculosis treatment has completed.
-
CLINICAL_TRIALS trial_result · 2020-07-17Clinical Trial Update: Efficacy Safety Study Comparing 2 Doses of NVP After Initiating Rifampin-containing TB Therapy [Phase 2]
Phase 2 trial comparing two doses of NVP (nevirapine) after initiating rifampin-containing TB therapy completed.
-
CLINICAL_TRIALS trial_result · 2020-07-17Clinical Trial Update: Pharmacokinetics (PK) and Safety of 2 Different Doses of Lopinavir/Ritonavir in in HIV/Tuberculosis (TB) Co-infected Patients Receiving Rifampicin Containing Anti-tuberculosis Therapy [Phase 2]
Phase 2 trial assessing pharmacokinetics and safety of two dose regimens of lopinavir/ritonavir in HIV/TB co-infected patients on rifampicin…
-
CLINICAL_TRIALS trial_result · 2020-06-30Clinical Trial Update: Efficacy of Weekly Rifapentine and Isoniazid for Tuberculosis Prevention [Phase 3]
Phase 3 trial update on weekly rifapentine and isoniazid for prevention of tuberculosis in silicosis and tuberculosis conditions.
-
CLINICAL_TRIALS trial_result · 2020-06-17Clinical Trial Update: Phase II Clinical Trial of Safety and Immunogenicity of Recombinant Subunit Tuberculosis Vaccine GamTBvac [Phase 2]
Phase II trial assessing safety and immunogenicity of the recombinant subunit tuberculosis vaccine GamTBvac has completed.
-
CLINICAL_TRIALS trial_result · 2020-05-06Clinical Trial Update: Evaluating PK, Tolerability, and Safety of Rifapentine and Isoniazid in Pregnant and Postpartum Women [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating pharmacokinetics, tolerability, and safety of rifapentine and isoniazid in pregnant and postpartum women…
-
CLINICAL_TRIALS trial_result · 2020-04-13Clinical Trial Update: Phase 1 Study of PBTZ169 [Phase 1]
Phase 1 study of PBTZ169 for tuberculosis has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-03-24Clinical Trial Update: Training Lay Healthcare Workers to Optimize TB Care and Improve Outcomes in Malawi [NA]
Completed clinical trial evaluating training lay healthcare workers to improve tuberculosis care and outcomes in Malawi; results posted in 2…
-
CLINICAL_TRIALS trial_result · 2020-03-24Clinical Trial Update: Taima TB: 3HP Study [Phase 4]
Phase 4 clinical trial update for Taima TB: 3HP study investigating regimen for tuberculosis has completed.
-
CLINICAL_TRIALS trial_result · 2020-03-18Clinical Trial Update: Rapid Detection of Rifampin and Isoniazid Resistance by PCR Before Tuberculosis (TB) Treatment Initiation [Phase 4]
Phase 4 clinical trial updating rapid PCR-based detection of rifampin and isoniazid resistance in tuberculosis before treatment initiation.
-
CLINICAL_TRIALS trial_result · 2020-03-09Clinical Trial Update: Phase 2a Study of PBTZ169 [Phase 2]
Phase 2a study of PBTZ169 for tuberculosis was terminated; results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2020-02-18Clinical Trial Update: Innovative Approach in Tuberculosis Care in Armenia [NA]
Clinical trial update for an innovative tuberculosis care approach completed in Armenia with results posted.
-
CLINICAL_TRIALS trial_result · 2020-02-13Clinical Trial Update: Optimization of the TB Treatment Regimen Cascade [Phase 3]
Phase 3 clinical trial update on optimizing the tuberculosis treatment regimen cascade; study completed with results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2020-02-12Clinical Trial Update: Pharmacokinetics and Safety of Rifabutin 150 mg Once Daily Versus Rifabutin 300 mg Thrice Weekly [Phase 2]
Phase 2 trial comparing pharmacokinetics and safety of rifabutin 150 mg daily versus 300 mg thrice weekly in HIV and tuberculosis.
-
CLINICAL_TRIALS trial_result · 2020-01-29Clinical Trial Update: Evaluating the Safety, Tolerability, and Pharmacokinetics of Bedaquiline and Delamanid, Alone and in Combination, For Drug-Resistant Pulmonary Tuberculosis [Phase 2]
Phase 2 trial evaluating safety, tolerability, and pharmacokinetics of bedaquiline and delamanid, alone and in combination, for drug-resista…
-
CLINICAL_TRIALS trial_result · 2019-12-19Clinical Trial Update: A Phase I/IIa AERAS-456 in HIV-Negative Adults With & Without Latent Tuberculosis Infection (C-035-456) [Phase 1, Phase 2]
Phase I/IIa trial update for AERAS-456 in HIV-negative adults with and without latent tuberculosis infection has completed with results post…
-
CLINICAL_TRIALS trial_result · 2019-12-17Clinical Trial Update: Potential Efficacy and Safety of Using Adjunctive Ibuprofen for XDR-TB Tuberculosis [Phase 2]
Phase 2 trial assessing adjunctive ibuprofen for efficacy and safety in XDR-TB tuberculosis; study completed.
-
CLINICAL_TRIALS trial_result · 2019-12-03Clinical Trial Update: Study to Evaluate the Efficacy of GlaxoSmithKline (GSK) Biologicals' Candidate Tuberculosis (TB) Vaccine in Adults [Phase 2]
Phase 2 trial update on GSK's TB vaccine in adults; study completed with results posted in 2019.